ANTI-beta(2)-GLYCOPROTEIN I ANTIBODIES ARE HIGHLY PREVALENT IN A LARGE NUMBER OF BRAZILIAN LEPROSY PATIENTS

ANTI-beta(2)-GLYCOPROTEIN I ANTIBODIES ARE HIGHLY PREVALENT IN A LARGE NUMBER OF BRAZILIAN LEPROSY PATIENTS

Author Ribeiro, Sandra Lucia Euzebio Autor UNIFESP Google Scholar
Pereira, Helena Lúcia Alves Autor UNIFESP Google Scholar
Silva, Neusa Pereira da Autor UNIFESP Google Scholar
Souza, Alexandre Wagner Silva de Autor UNIFESP Google Scholar
Sato, Emilia Inoue Autor UNIFESP Google Scholar
Institution Univ Fed Amazonas
Universidade Federal de São Paulo (UNIFESP)
Abstract Objectives: To determine the prevalence of anticardiolipin (aCL) and anti-beta(2)-glycoprotein I (anti-beta(2)GPI) antibodies in leprosy patients, during and after specific multidrug therapy (MDT), and to evaluate a possible association between these antibodies and some clinical characteristics of leprosy, including clinical forms, reactional episodes and treatment.Methods: The study included 158 leprosy patients, 129 gender-and-age matched healthy individuals, and 38 women with primary antiphospholipid syndrome (APS). Clinical and demographic characteristic of leprosy patients were collected, and serum samples, obtained from all participants, were kept frozen at - 20 degrees C. Antibodies were measured either by an in house-developed ELISA (aCL) or by a commercial ELISA (anti-beta(2)GPI).Results and Conclusions: Increased levels of aCL and anti-beta(2)GPI antibodies were found in leprosy patients and in the APS group, however, in contrast to APS, the predominant isotype in leprosy was IgM. The frequency of aCL and anti-beta(2)GPI antibodies was significantly higher in leprosy patients than in healthy individuals (15.8% vs. 3.1%; p < 0.01; 46.2% vs. 9.4%, p < 0.01), respectively. The lepromatous form predominated among aCL positive leprosy patients (p < 0.01). There was no difference in aCL and anti-beta(2)GPI positivity between leprosy patients taking MDT and those completed MDT as cured. Furthermore the duration of discharged period (period between discharge from MDT and the realization of the study) had no effect on anti-beta(2)GPI positivity, and a slight increase in aCL positivity was observed in patients with longer follow up periods (p=0.04), suggesting that the presence of antiphospholipid antibodies (aPL) was not a transient phenomenon. Although aPL in leprosy were frequent and beta(2)GPI-dependent as those found in APS, IgM was the predominant isotype, and there was no association with thrombosis or other APS manifestations.
Keywords Leprosy
Anti-beta(2)-glycoprotein I antibodies
Antiphospholipid antibodies
Anticardiolipin antibodies
Antiphospholipid syndrome
Language English
Date 2011-01-01
Published in Acta Reumatologica Portuguesa. Alges: Medfarma-edicoes Medicas, Lda, v. 36, n. 1, p. 30-37, 2011.
ISSN 0303-464X (Sherpa/Romeo, impact factor)
Publisher Medfarma-edicoes Medicas, Lda
Extent 30-37
Origin http://www.actareumatologica.pt/article_download.php?id=648
Access rights Open access Open Access
Type Article
Web of Science ID WOS:000288828700006
URI http://repositorio.unifesp.br/11600/42090

Show full item record




File

Name: WOS000288828700006.pdf
Size: 216.6Kb
Format: PDF
Description:
Open file

This item appears in the following Collection(s)

Search


Browse

Statistics

My Account